1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd. NSE: CAPLIPOINT | BSE: 524742
1773.90 47.10 (2.73%)
53,983
NSE+BSE Volume

NSE 30 Jan, 2026 3:51 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Caplin Point's arm gets US FDA nod for an anti-inflammatory drug, with US sales of ~$57.4 million See details